Overall, the abstracts seem to confirm the efficacy of Kyrpolis in MM. In an earl stage trial, it showed no benefit in CLL. Another abstract strongly confirmed the efficacy of Stivarga in GIST, The mystery abstract, #4, relates to sor
Sorry, hit the wrong key. (cont.) The mystery abstract, #4, relates to sorafenib in thyroid cancers, and will not be available online until June 2. Suggests that they are waiting to finalize some numbers, perhaps on OS. Tantalizing.